-
Infliximab, a
chimeric monoclonal antibody, sold
under the
brand name
Remicade among others, is a
medication used to
treat a
number of
autoimmune diseases...
- of a
monoclonal antibody to be
approved worldwide was a
biosimilar of
infliximab in the EU in 2013. On
March 6, 2015, the FDA
approved the
United States'...
- not infectious.
Treatments may
include corticosteroids, ciclosporin,
infliximab, or canakinumab. The
disease was
identified in 1930. It
affects approximately...
- 1988, a
monoclonal antibody called infliximab was
discovered at New York University's
School of Medicine.
Infliximab works by
binding to TNF, stopping...
- such as
infliximab from
binding antigen in a
laboratory test. Specifically,
neutralization occurs when the anti-drug
antibody binds to
infliximab's antigen...
-
Inhibition of TNF
effects can be
achieved with a
monoclonal antibody such as
infliximab, adalimumab,
certolizumab pegol, and golimumab, or with a circulating...
- (disease-modifying
antirheumatic drugs),
monoclonal antibodies, such as
infliximab and adalimumab, the TNF
inhibitor etanercept, and
methotrexate for moderate...
-
disease A
combination of
azathioprine and
infliximab treatment may be more
effective than a
single dose of
infliximab to
induce steroid-free
remission for...
- allergies,
azathioprine and antibodies,
including mepolizumab, omalizumab,
infliximab, and adalimumab. The word
enteritis (/ˌɛntəˈraɪtɪs/) uses
combining forms...
-
Trastuzumab Monoclonal antibodies used for
autoimmune diseases include infliximab and adalimumab,
which are
effective in
rheumatoid arthritis, Crohn's disease...
